GeneNews Ltd (TSE:GEN) shares rose 9.1% on Monday . The stock traded as high as C$0.12 and last traded at C$0.12. Approximately 745,435 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 1,520,729 shares. The stock had previously closed at C$0.11.
The stock has a market cap of $21.45 million and a P/E ratio of -1.62.
GeneNews Company Profile (TSE:GEN)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Featured Article: Cost of Goods Sold (COGS)
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.